Gynecologic cancer in pregnancy

Gynecologic malignancy in pregnancy

Gynecologic malignancy during pregnancy is a stressful problem. For the diagnosis and treatment of malignancy during pregnancy, a multidisciplinary approach is needed. Patients should be advised about the benefits and risk of treatment. When selecting a treatment for malignancy during pregnancy, the physiologic changes that occur with the pregnancy should be considered. Various diagnostic proce...

Gynecologic Issues in Peritoneal Dialysis 103 Pregnancy

This paper reviews the issues associated with the reproductive system in the special population of female patients with end-stage renal disease on peritoneal dialysis (PD). We summarize current knowledge concerning cancer screening tests, elective and urgent gynecologic procedures, and the issues of menstruation, contraception, pregnancy, and delivery in these patients. Finally, we present the ...

Hereditary Factors in Gynecologic Cancer.

Cancer predisposition in some families is known to be the result of germ-line mutations. The most noteworthy hereditary gynecologic cancer syndromes include hereditary breast-ovarian cancer (HBOC) syndrome, wherein BRCA1 and BRCA2 germ-line mutations have been identified, and hereditary nonpolyposis colorectal cancer (HNPCC) of the Lynch syndrome II variant, wherein hMSH2, hMLH1, hPMS2, hMSH3, ...

Global cooperation in gynecologic cancer.

Pelvic Exenteration in Gynecologic Cancer

Background: Pelvic exenteration is an ultraradical surgery involving the en bloc resection of the pelvic organs, including the internal reproductive organs, the distal urinary tract (ureters, bladder, urethra), and/or anorectum. It is mainly applied as a salvage surgery for recurrent gynecologic tumors of any origin (vulva, vagina, cervix, uterine, and also ovary). Our aim was to establish the ...